(4) Pre-preparation of information materials
Q(Question)
For information on off-label drugs or dosages not approved domestically that is frequently requested by physicians or pharmacists, is it permissible to prepare in advance, through appropriate internal procedures, a response document that complies with the Guidelines, and to provide that document when a physician or pharmacist requests information?
A(MHLW answer)
There is no objection to preparing such a response document in advance in the described situation; however, when providing the response document in response to a request from a healthcare professional, it is necessary to confirm that the content of the document aligns with what the healthcare professional has requested.
Items requiring particular attention: (2), (3)
So what (meaning): Pre-approved response documents for frequently asked questions are permissible, but before handing one over the representative must verify that the document's content actually matches what the specific physician or pharmacist requested — mechanical distribution without checking the fit is not acceptable.
So why (rationale): Pre-preparation itself does not violate the Guidelines, but since provision of off-label information is only permitted in response to an individual request from a healthcare professional, confirmation of content alignment is required at the time of provision.
Commentary — background, application, practical notes
Medical information and scientific affairs teams sometimes prepare pre-approved standard response documents to avoid the inefficiency and quality variability of building responses from scratch for every inquiry on frequently requested off-label topics. Q9 acknowledges this operational rationale while mandating a content-alignment check at the point of use, to ensure that pre-prepared documents do not become a backdoor for unsolicited provision.
A typical workflow involves a specialist committee reviewing and approving a standard response document for an off-label use that generates dozens of inquiries annually. When an inquiry arrives, the representative verifies that the document's content actually matches what the specific physician or pharmacist asked before handing it over. Mechanically distributing the same document without performing that verification — even for inquiries on the same general topic — does not meet the requirement.
A practical difficulty arises when the inquiry differs subtly from the scope covered by the pre-prepared document. For example, if the document addresses dosing for adult patients of standard body weight but the inquiry concerns dose adjustment for a patient with renal impairment, only part of the document is relevant. In that case, the representative must either provide only the applicable sections or prepare separate information that addresses the actual question. Handing over the full document with a note to 'use the relevant parts' is not an acceptable approach.
Source: MHLW MSA Guidelines Q&A Part 2, Mar 29 2019, Q9